{"id":6468,"date":"2020-04-30T15:01:26","date_gmt":"2020-04-30T22:01:26","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=6468"},"modified":"2021-03-12T15:02:18","modified_gmt":"2021-03-12T23:02:18","slug":"successful-manufacturing-of-clinical-grade-sars-cov-2-specific-t-cells-for-adoptive-cell-therapy","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/04\/30\/successful-manufacturing-of-clinical-grade-sars-cov-2-specific-t-cells-for-adoptive-cell-therapy\/","title":{"rendered":"Successful manufacturing of clinical-grade SARS-CoV-2 specific T Cells for adoptive cell therapy"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Leung et al. demonstrate that clinical-grade SARS-CoV-2 specific T cells can be isolated from the blood of convalescent donors rapidly and efficiently using SARS-CoV-2 specific peptides and an automated medical device expedient for emergent treatment of severe COVID-19 disease until effective vaccines or treatment are developed.\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Leung et al. (Apr 30, 2020). Successful manufacturing of clinical-grade SARS-CoV-2 specific T Cells for adoptive cell therapy. Pre-print downloaded Apr 30 from <\/span><\/i><a href=\"https:\/\/doi.org\/10.1101\/2020.04.24.20077487\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1101\/2020.04.24.20077487<\/span><\/a><i><span style=\"font-weight: 400\">\u00a0<\/span><\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Leung et al. demonstrate that clinical-grade SARS-CoV-2 specific T cells can be isolated from the blood of convalescent donors rapidly and efficiently using SARS-CoV-2 specific peptides and an automated medical device expedient for emergent treatment of severe COVID-19 disease until effective vaccines or treatment are developed.\u00a0 Leung et al. (Apr 30, 2020). Successful manufacturing of&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/04\/30\/successful-manufacturing-of-clinical-grade-sars-cov-2-specific-t-cells-for-adoptive-cell-therapy\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[19],"class_list":["post-6468","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-testing-and-treatment"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=6468"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6468\/revisions"}],"predecessor-version":[{"id":6469,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/6468\/revisions\/6469"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=6468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=6468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=6468"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=6468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}